| scholarly article | Q13442814 |
| P50 | author | Pleuni S. Pennings | Q55437566 |
| Sarah Cobey | Q56072288 | ||
| P2093 | author name string | Gabriel G Perron | |
| R Fredrik Inglis | |||
| P2860 | cites work | Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria | Q22121986 |
| The genetic theory of adaptation: a brief history | Q22122021 | ||
| Distribution of fitness effects among beneficial mutations before selection in experimental populations of bacteria | Q22122042 | ||
| Lateral gene transfer and the nature of bacterial innovation | Q22122396 | ||
| Ubiquity of Biological Ice Nucleators in Snowfall | Q22242277 | ||
| A new antibiotic kills pathogens without detectable resistance | Q24091299 | ||
| Mutations of Bacteria from Virus Sensitivity to Virus Resistance | Q24533278 | ||
| Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective | Q24535810 | ||
| The Distribution of Fitness Effects Among Beneficial Mutations | Q24543521 | ||
| Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli | Q24613078 | ||
| Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis | Q24625342 | ||
| Replica plating and indirect selection of bacterial mutants | Q24676225 | ||
| Staphylococcal infection due to penicillin-resistant strains | Q24684917 | ||
| The fitness costs of antibiotic resistance mutations | Q26825334 | ||
| Who will develop new antibacterial agents? | Q26851875 | ||
| Antibiotic resistance is ancient | Q27672681 | ||
| Costs of antibiotic resistance - separating trait effects and selective effects | Q28082095 | ||
| SOS Repair Hypothesis: Phenomenology of an Inducible DNA Repair Which is Accompanied by Mutagenesis | Q28141658 | ||
| Do bacteria have sex? | Q28210616 | ||
| Evolution of mutation rates in bacteria | Q28238561 | ||
| Functional characterization of the antibiotic resistance reservoir in the human microflora | Q28256703 | ||
| Mechanisms of, and barriers to, horizontal gene transfer between bacteria | Q28270244 | ||
| Acinetobacter baylyi as a pathogen for opportunistic infection | Q28287437 | ||
| A comparative study on the cost of new antibiotics and drugs of other therapeutic categories | Q28469093 | ||
| A reservoir of drug-resistant pathogenic bacteria in asymptomatic hosts | Q28474039 | ||
| The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa | Q28474903 | ||
| Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations | Q28476356 | ||
| Selection of resistant bacteria at very low antibiotic concentrations | Q28479239 | ||
| Functional characterization of bacteria isolated from ancient arctic soil exposes diverse resistance mechanisms to modern antibiotics | Q28651559 | ||
| Drugs for bad bugs: confronting the challenges of antibacterial discovery | Q29547723 | ||
| Darwinian evolution can follow only very few mutational paths to fitter proteins | Q29616042 | ||
| Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer | Q29616236 | ||
| Origins and evolution of antibiotic resistance | Q29617791 | ||
| Antibacterial resistance worldwide: causes, challenges and responses | Q29620008 | ||
| Cooperation and competition in pathogenic bacteria | Q30050246 | ||
| Evolution of the serine beta-lactamases: past, present and future. | Q30341612 | ||
| Livestock origin for a human pandemic clone of community-associated methicillin-resistant Staphylococcus aureus | Q30352838 | ||
| Dissemination of multidrug-resistant bacteria into the Arctic | Q37008929 | ||
| Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids | Q37189738 | ||
| Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium | Q37204246 | ||
| Antibiotics in the aquatic environment--a review--part I. | Q37382825 | ||
| Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis. | Q37404250 | ||
| Cycling antibiotics may not be good for your health | Q37513152 | ||
| The Role of Spontaneous Variants in the Acquisition of Streptomycin Resistance by the Shigellae | Q37530985 | ||
| The role of antibiotics and antibiotic resistance in nature | Q37551128 | ||
| Bacterial gene amplification: implications for the evolution of antibiotic resistance | Q37553896 | ||
| Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections | Q37598703 | ||
| Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment | Q37604241 | ||
| Call of the wild: antibiotic resistance genes in natural environments | Q37700168 | ||
| The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. | Q37755968 | ||
| Molecular mechanisms of epistasis within and between genes | Q37891527 | ||
| Microbiota-targeted therapies: an ecological perspective | Q38016805 | ||
| The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria | Q38076545 | ||
| Empirical fitness landscapes and the predictability of evolution | Q38218962 | ||
| Mutations of intermediate effect are responsible for adaptation in evolving Pseudomonas fluorescens populations | Q38786690 | ||
| Microbial evolution. Global epistasis makes adaptation predictable despite sequence-level stochasticity | Q39169158 | ||
| Diminishing returns epistasis among beneficial mutations decelerates adaptation | Q39954065 | ||
| Induced Resistance of Staphylococcus aureus to Various Antibiotics. | Q40041140 | ||
| Origin of Bacterial Resistance to Antibiotics. | Q40046023 | ||
| The rate of environmental change drives adaptation to an antibiotic sink | Q40062779 | ||
| The competitive cost of antibiotic resistance in Mycobacterium tuberculosis | Q40311130 | ||
| Sampling the antibiotic resistome | Q40357052 | ||
| Natural antibiotic resistance and contamination by antibiotic resistance determinants: the two ages in the evolution of resistance to antimicrobials | Q40385075 | ||
| Inactivation of antibiotics and the dissemination of resistance genes | Q40737331 | ||
| Diminishing Returns From Beneficial Mutations and Pervasive Epistasis Shape the Fitness Landscape for Rifampicin Resistance in Pseudomonas aeruginosa | Q41166962 | ||
| Selection of a multidrug resistance plasmid by sublethal levels of antibiotics and heavy metals | Q41712060 | ||
| Social evolution in micro-organisms and a Trojan horse approach to medical intervention strategies. | Q41817819 | ||
| Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene | Q41864870 | ||
| Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
| Large-scale metagenomic-based study of antibiotic resistance in the environment | Q42215944 | ||
| Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. | Q42246515 | ||
| The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach | Q42659717 | ||
| Contribution of gene amplification to evolution of increased antibiotic resistance in Salmonella typhimurium | Q43067316 | ||
| Parallel evolution of multidrug-resistance in Salmonella enterica isolated from swine | Q43888384 | ||
| Negative epistasis between beneficial mutations in an evolving bacterial population | Q44010374 | ||
| Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance | Q44144059 | ||
| Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium | Q44666207 | ||
| Functional metagenomics reveals diverse beta-lactamases in a remote Alaskan soil | Q47651450 | ||
| Rotating antibiotics selects optimally against antibiotic resistance, in theory | Q48199964 | ||
| Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. | Q51705053 | ||
| The cost of multiple drug resistance in Pseudomonas aeruginosa. | Q51760149 | ||
| An enzyme from bacteria able to destroy penicillin. 1940. | Q52397925 | ||
| Streptomycin resistant variants obtained from recently isolated cultures of tubercle bacilli. | Q52694386 | ||
| Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations. | Q53399821 | ||
| Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa. | Q53413637 | ||
| Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. | Q53876940 | ||
| An Enzyme from Bacteria able to Destroy Penicillin | Q54138191 | ||
| Changing pattern of resistance of staphylococci to antibiotics. | Q54338918 | ||
| Antibiotic resistant mutants of Escherichia coli K12 show increases in heterologous gene expression | Q54375566 | ||
| Protection of Salmonella by ampicillin-resistant Escherichia coli in the presence of otherwise lethal drug concentrations. | Q54400707 | ||
| Functional classification of drugs by properties of their pairwise interactions. | Q54468515 | ||
| Fitness effects of fixed beneficial mutations in microbial populations. | Q54541810 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Enzymes that inactivate antibiotics in transit to their targets | Q54637979 | ||
| The development of bacterial resistance to chemotherapeutic agents. | Q54752360 | ||
| Streptomycin resistance in pulmonary tuberculosis. | Q54753261 | ||
| Infection by penicillin-resistant staphylococci. | Q54753389 | ||
| Studies on the action of penicillin; further observations on the development of penicillin resistance by meningococcus in vitro. | Q54754376 | ||
| Experimental evolution of resistance to an antimicrobial peptide. | Q54949785 | ||
| Group-beneficial traits, frequency-dependent selection and genotypic diversity: an antibiotic resistance paradigm. | Q55435439 | ||
| Evolutionary Chance Mutation: A Defense of the Modern Synthesis' Consensus View | Q56504411 | ||
| Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa | Q56897124 | ||
| Diminishing Returns from Mutation Supply Rate in Asexual Populations | Q56920120 | ||
| Underappreciated Role of Regionally Poor Water Quality on Globally Increasing Antibiotic Resistance | Q57651325 | ||
| Why do bacteria engage in homologous recombination? | Q57942124 | ||
| The antibiotic alarm | Q59098649 | ||
| Hospital cross-infections with staphylococci resistant to several antibiotics. | Q64901990 | ||
| The production and role of antibiotics in soil | Q67867762 | ||
| The assessment of antimicrobial combinations | Q70178739 | ||
| Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic | Q72135344 | ||
| Adaptation to the fitness costs of antibiotic resistance in Escherichia coli | Q73792447 | ||
| The population genetics of adaptation: the adaptation of DNA sequences | Q74699508 | ||
| Genetics of microorganisms | Q75764294 | ||
| Chemotherapy for staphylococcus aureus in burns | Q76113949 | ||
| Mutagenic action of manganous chloride | Q76199559 | ||
| Mutagenic effect of azaserine in relation to azaserine resistance in Escherichia coli | Q78573784 | ||
| Intermediary metabolism and antibiotic synthesis | Q79358941 | ||
| Incidence of penicillin-resistant and streptomycin-resistant staphylococci in a hospital | Q80383499 | ||
| Aureomycin in the treatment of penicillin-resistant staphylococcic bacteremia | Q80386840 | ||
| Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus | Q80832162 | ||
| Antibiotics and antibiotic resistance genes in natural environments | Q81659169 | ||
| The action of penicillin on staphylococci | Q82145739 | ||
| Need for both antibiotic cycling and stringent environmental controls to prevent Pseudomonas infections | Q83709424 | ||
| Hypermutability and compensatory adaptation in antibiotic-resistant bacteria | Q84562380 | ||
| Temporary Character of "Fastness" of Staphylococci to Penicillin | Q84941100 | ||
| Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments | Q84975610 | ||
| Evolution and ecology of antibiotic resistance genes | Q34626797 | ||
| Specialized DNA polymerases, cellular survival, and the genesis of mutations | Q34662609 | ||
| The cost of antibiotic resistance depends on evolutionary history in Escherichia coli. | Q34893085 | ||
| Impacts of anthropogenic activity on the ecology of class 1 integrons and integron-associated genes in the environment | Q35135774 | ||
| The mutant selection window and antimicrobial resistance | Q35153856 | ||
| The role of mutators in the emergence of antibiotic-resistant bacteria | Q35177659 | ||
| Public health evolutionary biology of antimicrobial resistance: priorities for intervention | Q35236703 | ||
| Antibiotics in agriculture and the risk to human health: how worried should we be? | Q35236707 | ||
| Role of pleiotropy during adaptation of TEM-1 β-lactamase to two novel antibiotics | Q35236711 | ||
| Understanding genetic variation in in vivo tolerance to artesunate: implications for treatment efficacy and resistance monitoring | Q35236718 | ||
| What traits are carried on mobile genetic elements, and why? | Q35246646 | ||
| Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. | Q35635595 | ||
| Epidemiology of drug resistance: implications for a post-antimicrobial era | Q35748958 | ||
| Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution | Q35811223 | ||
| THE MECHANISM OF CHEMICAL MUTAGENESIS. I. KINETIC STUDIES ON THE ACTION OF TRIETHYLENE MELAMINE (TEM) AND AZASERINE. | Q35966490 | ||
| Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro | Q36095041 | ||
| Efflux-mediated antimicrobial resistance | Q36138147 | ||
| Clinical and economic impact of common multidrug-resistant gram-negative bacilli | Q36482801 | ||
| Multidrug-resistance efflux pumps - not just for resistance | Q36538111 | ||
| Evaluating treatment protocols to prevent antibiotic resistance | Q36637189 | ||
| Antibiotics as signalling molecules | Q36732540 | ||
| β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity | Q36737307 | ||
| Exploiting social evolution in biofilms. | Q36823972 | ||
| Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs | Q36910633 | ||
| Drug interactions modulate the potential for evolution of resistance | Q36937085 | ||
| The comprehensive antibiotic resistance database. | Q36969864 | ||
| Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. | Q30426714 | ||
| Evolutionary rescue: an emerging focus at the intersection between ecology and evolution. | Q30580050 | ||
| Evolutionary rescue from extinction is contingent on a lower rate of environmental change | Q30587544 | ||
| Positive epistasis drives the acquisition of multidrug resistance | Q33486486 | ||
| Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. | Q33520054 | ||
| The biological cost of antibiotic resistance | Q33745219 | ||
| Waste water effluent contributes to the dissemination of CTX-M-15 in the natural environment | Q33746048 | ||
| Drug interactions and the evolution of antibiotic resistance | Q33792926 | ||
| The shared antibiotic resistome of soil bacteria and human pathogens | Q33804392 | ||
| The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions | Q33890335 | ||
| Resolution of gene regulatory conflicts caused by combinations of antibiotics | Q33906373 | ||
| Discovery research: the scientific challenge of finding new antibiotics | Q33941796 | ||
| Humans as the world's greatest evolutionary force | Q33954568 | ||
| HIV and AIDS: 20 years of science | Q33966893 | ||
| Induction of microbial secondary metabolism. | Q34003831 | ||
| Antagonism between bacteriostatic and bactericidal antibiotics is prevalent | Q34058001 | ||
| Population structure and evolutionary dynamics of pathogenic bacteria | Q34085658 | ||
| Is there a role for antibiotic cycling in the intensive care unit? | Q34212069 | ||
| Identification of New Delhi metallo-β-lactamase 1 in Acinetobacter lwoffii of food animal origin | Q34281777 | ||
| The crisis in antibiotic resistance | Q34314442 | ||
| Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. | Q34332938 | ||
| Resistance to antibiotics mediated by target alterations | Q34339223 | ||
| Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals | Q34340879 | ||
| The scourge of antibiotic resistance: the important role of the environment | Q34347746 | ||
| Tackling antibiotic resistance | Q34390844 | ||
| Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance | Q34407557 | ||
| Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review | Q34429286 | ||
| Perspective: Sign epistasis and genetic constraint on evolutionary trajectories | Q34437784 | ||
| Missense meanderings in sequence space: a biophysical view of protein evolution | Q34439602 | ||
| Prediction of antibiotic resistance by gene expression profiles. | Q34454311 | ||
| The biological cost of mutational antibiotic resistance: any practical conclusions? | Q34554396 | ||
| Compensatory evolution in rifampin-resistant Escherichia coli | Q34610970 | ||
| The evolution of mutator genes in bacterial populations: the roles of environmental change and timing. | Q34617981 | ||
| P433 | issue | 3 | |
| P921 | main subject | public health | Q189603 |
| evolutionary biology | Q840400 | ||
| P304 | page(s) | 211-222 | |
| P577 | publication date | 2015-03-23 | |
| P1433 | published in | Evolutionary Applications | Q15758978 |
| P1476 | title | Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health | |
| P478 | volume | 8 |
| Q64096949 | Antibiotic Treatment Drives the Diversification of the Human Gut Resistome |
| Q47631000 | Environmental factors influencing the development and spread of antibiotic resistance |
| Q91750481 | Genomic Comparison Reveals Natural Occurrence of Clinically Relevant Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Escherichia coli Strains |
| Q48045763 | Human dissemination of genes and microorganisms in Earth's Critical Zone |
| Q42001022 | Iron availability shapes the evolution of bacteriocin resistance in Pseudomonas aeruginosa |
| Q37539878 | Manipulating virulence factor availability can have complex consequences for infections |
| Q28079255 | Molecular and cellular bases of adaptation to a changing environment in microorganisms |
| Q37612971 | Mutations Associated with Decreased Susceptibility to Seven Antimicrobial Families in Field and Laboratory-Derived Mycoplasma bovis Strains |
| Q36012638 | Perspectives on the evolutionary ecology of arthropod antimicrobial peptides. |
| Q47547382 | Slow and temperature-mediated pathogen adaptation to a nonspecific fungicide in agricultural ecosystem. |
| Q58833829 | Surface deposited one-dimensional copper-doped TiO2 nanomaterials for prevention of health care acquired infections |
| Q50330231 | The One Health Concept: 10 Years Old and a Long Road Ahead |
| Q36407945 | With a little help from my friends: cooperation can accelerate the rate of adaptive valley crossing |
Search more.